NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-030-2004-0-US-07 Novel Schweinfurthin Analogs As Anticancer Agents US CON 12/025,617 7902228 Abandoned PDF
NCI E-331-2007-0-US-01 VIRAL INACTIVATION USING CROSSLINKERS AND DETERGENTS US 61/025,424 Abandoned
NCI E-003-2007-0-US-01 ENGINEERED ANTIBODY CONSTANT DOMAIN MOLECULES US 61/063,245 Abandoned
NCI E-090-2008-0-US-01 SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH RENAL DISEASE US 61/024,863 Abandoned
NICHD E-057-2008-0-US-01 Method for Treating Uterine Fibroids US ORD 12/021,610 8299050 Issued PDF
NCI E-258-2005-0-US-07 METHOD FOR DETERMINING REDOX STATUS OF A TISSUE US National Stage 11/997,236 Abandoned
NIAID E-129-2003-0-US-04 CD+25 Differential Markers and Uses Thereof US DIV 12/023,470 Abandoned
NCI E-002-1996-1-US-17 Mesothelium Antigen and Methods and Kits For Targeting It US DIV 12/021,151 Abandoned
NCI E-065-2008-0-US-01 METHOD OF DETERMINING BREAST CANCER RISK US 61/023,936 Abandoned
NCI E-211-2005-0-CA-04 Use Of Chk2 Kinase Inhibitors For Cancer Treatment CA National Stage 2617150 Abandoned
NIDA E-283-2006-0-PCT-02 MODULATORS OF THE METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE 5 AND USES THEREOF PCT PCT PCT/US2008/052032 Abandoned
NCI E-073-2007-0-US-06 Identification Of T219 As A Major, Functionally Important Phosphorylation Site On PKC-theta US National Stage 11/919,178 Abandoned
NCI E-060-2000-1-US-08 SFRP And Peptide Motifs That Interact With SFRP And Methods Of Their Use US DIV 12/019,567 8334260 Expired PDF
NCI E-018-1999-1-US-02 Molecular Motor US DIV 12/011,239 8086432 Abandoned PDF
NIAID E-050-2008-1-US-01 INFLUENZA DNA VACCINATION AND METHODS OF USE THEREOF US 61/023,341 Abandoned
NCI E-250-2007-0-US-01 INDUCED INTERNALIZATION OF SURFACE RECEPTORS US 61/023,397 Abandoned
NIAID E-115-2001-3-US-09 MVA Expressing Modified HIV Envelope, Gag And Pol Genes US CON 12/018,150 7867982 Expired PDF
NCI E-077-2008-0-US-01 Use Of HPV Virus-like Particles To Deliver Gene-based Vaccines US 61/022,324 Abandoned
NIAMS E-042-2005-0-US-03 Bioreactor Device, and Method and System For Fabricating Tissues in the Bioreactor Device US National Stage 11/989,051 8709793 Abandoned PDF
NICHD E-096-2007-3-PCT-01 Method For Predicting And Detecting Tumor Metastasis PCT PCT COMB PCT/US2008/051438 Abandoned
NHLBI E-196-1998-2-US-15 Method for Pressure Mediated Selective Delivery of Therapeutic Substances And Cannula US DIV 12/009,646 Abandoned
OD E-212-2006-0-US-01 A Method For A 256-second, 500 Slice Magnetic Resonance Imaging (MRI) Whole-Body Scan With 1.5 Mm Inplane Resolution And 2 Mm Through-plane Resolution US 61/021,707 Abandoned
OD E-213-2006-0-US-01 A Method For Improving The Signal-to-Noise Ratio In Magnetic Resonance Imaging (MRI) Whole-Body Scans US 61/021,707 Abandoned
OD E-322-2006-0-US-01 A Method For Increasing The Number Of Simultaneously Acquired Slices In Interleaved Pulsed MAMBA US 61/021,707 Abandoned
NIAID E-087-2008-0-US-01 DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN US 61/021,865 Abandoned
NIAID E-050-2008-0-US-01 Vaccination Strategies To Develop Protective, Persistent, High Immune Response For Use In Chickens, Other Bird Species, And Potentially Mammals, Toward Protection Against Avian Influenza And Other Pathogenic Infections US 61/021,586 Abandoned
NCI E-275-2007-0-PCT-02 CD45, A Protein Tyrosine Phosphatase As A Therapeutic Target For Multiple Pathogenic Organisms PCT PCT PCT/2008/00050976 Expired
NCI E-103-2007-0-PCT-02 Improved DNA Vaccination Protocols PCT PCT PCT/US2008/051004 Expired
NCI E-059-2007-2-CA-03 GP100-SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CA National Stage 2674445 Abandoned
NCI E-059-2007-2-CH-08 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CH EP 08727582.2 Abandoned
NCI E-059-2007-2-GB-11 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE GB EP 08727582.2 Abandoned
NCI E-059-2007-2-EP-04 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE EP National Stage 08727582.2 Abandoned
NCI E-059-2007-2-FR-10 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE FR EP 08727582.2 Abandoned
NCI E-059-2007-2-DE-09 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE DE EP 08727582.2 Abandoned
NCI E-059-2007-2-AU-02 GP100- SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE AU National Stage 2008206442 Abandoned
NIAID E-046-2007-0-PCT-02 Universal And Specific Quantitative Detection Of Clostridium Botulinum PCT PCT PCT/US2008/050872 Expired
NCI E-059-2007-2-PCT-01 GP-100 SPECIFIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE PCT PCT COMB PCT/US08/050841 Expired
NIDDK E-021-2007-0-PCT-02 METHOD TO IDENTIFY INHIBITORS OF CELL SICKLING PCT PCT PCT/US08/000427 Expired
NIAID E-323-2005-2-JP-07 Vaccines Against Potential Pandemic Strains of Influenza JP National Stage 2008500042 Abandoned
NIAMS E-011-2007-0-US-02 Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology US ORD 11/972,395 Abandoned
NCI E-086-1999-0-US-08 Molecular Diagnosis of Disseminated Candida Albicans Infection Using Hemoglobin-Response Gene US DIV 11/971,454 Abandoned
NCATS E-055-2008-0-US-01 Phosphodiesterase Inhibitors US 61/020,079 Abandoned
NCI E-083-2007-0-AU-03 SLCO1B3 GENOTYPE AU National Stage 2008205330 Abandoned
NCI E-083-2007-0-FR-08 SLCO1B3 GENOTYPE FR EP 08713083.7 Abandoned
NCI E-083-2007-0-DE-07 SLCO1B3 GENOTYPE DE EP 08713083.7 Abandoned
NCI E-083-2007-0-GB-09 SLCO1B3 GENOTYPE GB EP 08713083.7 Abandoned
NCI E-083-2007-0-EP-05 SLCO1B3 GENOTYPE EP National Stage 08713083.7 Abandoned
NCI E-083-2007-0-PCT-02 SLCO1B3 GENOTYPE PCT PCT PCT/US2008/000310 Expired
NCI E-083-2007-0-CA-04 SLCO1B3 GENOTYPE CA National Stage 2674788 Abandoned
NCI E-137-2005-0-US-03 METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS US National Stage 11/988,427 Abandoned